Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-09-08 to 2022-10-11
Current total value of award: $87.2
Description: 8509376500!OMEPRAZOLE EXTENDED